Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter‐Targeting Nanoparticles: A Case Study of High‐Efficiency SLC22A5 (OCTN2)‐Mediated Carnitine‐Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs
Authors:
- 29 June 2017
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 6 (17)
Abstract
OCTN2 (SLC22A5) is a Na+‐coupled absorption transporter for l‐carnitine in small intestine. This study tests the potential of this transporter for oral delivery of therapeutic drugs encapsulated in l‐carnitine‐conjugated poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles (LC‐PLGA NPs) and discloses the molecular mechanism for cellular endocytosis of transporter‐targeting nanoparticles. Conjugation of l‐carnitine to a surface of PLGA‐NPs enhances the cellular uptake and intestinal absorption of encapsulated drug. In both cases, the uptake process is dependent on cotransporting ion Na+. Computational OCTN2 docking analysis shows that the presence of Na+ is important for the formation of the energetically stable intermediate complex of transporter‐Na+‐LC‐PLGA NPs, which is also the first step in cellular endocytosis of nanoparticles. The transporter‐mediated intestinal absorption of LC‐PLGA NPs occurs via endocytosis/transcytosis rather than via the traditional transmembrane transport. The portal blood versus the lymphatic route is evaluated by the plasma appearance of the drug in the control and lymph duct‐ligated rats. Absorption via the lymphatic system is the predominant route in the oral delivery of the NPs. In summary, LC‐PLGA NPs can effectively target OCTN2 on the enterocytes for enhancing oral delivery of drugs and the critical role of cotransporting ions should be noticed in designing transporter‐targeting nanoparticles.Keywords
Funding Information
- National Natural Science Foundation of China (81473164, 81503020, U1608283)
- Texas Tech University
- China Scholarship Council (201508210200)
This publication has 29 references indexed in Scilit:
- Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOsEuropean Journal of Radiology, 2012
- Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1Journal of Pharmaceutical Sciences, 2011
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyondPharmacology & Therapeutics, 2009
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences, 2008
- Organic Cation/Carnitine Transporter OCTN2 (Slc22a5) Is Responsible for Carnitine Transport across Apical Membranes of Small Intestinal Epithelial Cells in MouseMolecular Pharmacology, 2006
- XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute TransportersThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Transport of Amino Acid-Based Prodrugs by the Na+- and Cl--Coupled Amino Acid Transporter ATB0,+ and Expression of the Transporter in Tissues Amenable for Drug DeliveryThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2Biochemical and Biophysical Research Communications, 1998
- cDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter FamilyBiochemical and Biophysical Research Communications, 1998